LHC Group, Inc. (LHCG) EPS Estimated At $0.60

April 17, 2018 - By Paula Hilliard

LHC Group, Inc. (NASDAQ:LHCG) LogoInvestors sentiment decreased to 1.15 in 2017 Q4. Its down 0.35, from 1.5 in 2017Q3. It turned negative, as 30 investors sold LHC Group, Inc. shares while 56 reduced holdings. 38 funds opened positions while 61 raised stakes. 15.67 million shares or 2.23% more from 15.33 million shares in 2017Q3 were reported.
Petrus Tru Comm Lta reported 4,679 shares. Voya Inv Limited Company has 0% invested in LHC Group, Inc. (NASDAQ:LHCG) for 36,946 shares. 118,258 were accumulated by Goldman Sachs Group. Koch Industry Incorporated holds 0.09% or 10,228 shares in its portfolio. Commercial Bank Of Montreal Can reported 0% stake. Product Prtnrs Ltd Liability Corp holds 110,400 shares. Blackrock Incorporated accumulated 2.45M shares. Gsa Cap Prns Llp holds 16,213 shares. Hanseatic Management owns 17 shares. Cadence Cap Mngmt Limited Liability Com invested in 0.11% or 28,727 shares. Advisory Svcs Net Lc holds 0% of its portfolio in LHC Group, Inc. (NASDAQ:LHCG) for 74 shares. Moreover, Thrivent For Lutherans has 0% invested in LHC Group, Inc. (NASDAQ:LHCG) for 10,130 shares. Wells Fargo And Mn invested in 0% or 102,509 shares. Coliseum Cap Mgmt Limited Liability invested in 100,000 shares. Ubs Asset Management Americas Inc accumulated 0% or 5,200 shares.

Since March 13, 2018, it had 0 insider purchases, and 1 sale for $909,824 activity.

Analysts expect LHC Group, Inc. (NASDAQ:LHCG) to report $0.60 EPS on May, 2.They anticipate $0.12 EPS change or 25.00 % from last quarter’s $0.48 EPS. LHCG’s profit would be $18.72M giving it 30.08 P/E if the $0.60 EPS is correct. After having $0.62 EPS previously, LHC Group, Inc.’s analysts see -3.23 % EPS growth. The stock increased 1.52% or $1.08 during the last trading session, reaching $72.19. About 91,471 shares traded. LHC Group, Inc. (NASDAQ:LHCG) has risen 15.17% since April 17, 2017 and is uptrending. It has outperformed by 3.62% the S&P500.

LHC Group, Inc. (NASDAQ:LHCG) Ratings Coverage

Among 8 analysts covering LHC Group (NASDAQ:LHCG), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. LHC Group had 11 analyst reports since November 2, 2017 according to SRatingsIntel. The stock has “Buy” rating by William Blair on Tuesday, January 23. The firm has “Buy” rating given on Thursday, November 2 by SunTrust. RBC Capital Markets maintained LHC Group, Inc. (NASDAQ:LHCG) rating on Tuesday, November 7. RBC Capital Markets has “Buy” rating and $81.0 target. The rating was maintained by Oppenheimer with “Outperform” on Friday, November 17. Craig Hallum maintained it with “Buy” rating and $80.0 target in Tuesday, November 7 report. As per Monday, November 27, the company rating was maintained by Robert W. Baird. The firm has “Buy” rating given on Tuesday, November 7 by Jefferies. As per Tuesday, November 7, the company rating was maintained by Oppenheimer. The firm has “Buy” rating by Stephens given on Thursday, March 1. The firm earned “Buy” rating on Thursday, November 2 by Jefferies.

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company has market cap of $2.25 billion. The firm operates through four divisions: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. It has a 25.87 P/E ratio. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

LHC Group, Inc. (NASDAQ:LHCG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: